Pharmaceutical / Drug Definition :
Interferes with bacterial cell-wall synthesis and division by binding to cell wall, causing cell to die. Active against gram-negative and gram-positive bacteria, with expanded activity against gram-negative bacteria. Exhibits minimal immunosuppressant activity.
In the United States, Ceftriaxone Sodium is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Ceftriaxone Sodium.
FDA Label Requirements and Exceptions
FDA Import Information
Ceftriaxone Sodium (Ceftriaxone Sodium Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Ceftriaxone Sodium (Ceftriaxone Sodium Suppliers)
- Processors Ceftriaxone Sodium
- Repackers Ceftriaxone Sodium
- Relabelers Ceftriaxone Sodium
- Exporters Ceftriaxone Sodium
- Importers Ceftriaxone Sodium
For more information about Ceftriaxone Sodium, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.